ArticleAddiction science & clinical practice2021

Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.

Travis M Scott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.